FCGR3A, also named CD16, was linked to patient susceptibility to recurrent viral infections (Vivier et al., 2008), and its gene polymorphisms were related to patient susceptibility to BD (Zhang et al., 2018). Here, FCGR3A is linked to viral infectious disease.